Drugs / DWC202005
last change Nov 2020 re-read 2 minutes ago

DWC202005

Investigated by
Daewoong Pharmaceutical Co. LTD.

Trials 1 · a red edge is where a trial was stopped

202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT04328766 Sep → Nov 2020 Daewoong Pharmaceutical Co. LTD. Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as DWC202005 ClinicalTrials.gov intervention name — accepted as the source's own label NCT04328766